dalbavancin 500 MG Injection [Dalvance]
- RxCUI
- 1539248
- RxNorm name
- dalbavancin 500 MG Injection [Dalvance]
- Display name
- dalbavancin 500 MG Injection [Dalvance]
- Full name
- dalbavancin 500 MG Injection [Dalvance]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:57
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DALVANCE | DALBAVANCIN | Allergan, Inc. | 4b4674d8-4d1e-4728-8465-d42ada33fa5c | 2025-01-13 | Warnings, Adverse reactions | 1539248 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4b4674d8-4d1e-4728-8465-d42ada33fa5c | dalbavancin 500 MG Injection [Dalvance] | SBD | 29 | These highlights do not include all the information needed to use DALVANCE ® safely and effectively. See full prescribing information for DALVANCE . DALVANCE ( dalbavancin ) for injection , for intravenous use Initial U.S. Approval: 2014 | 20250113 |
| 4b4674d8-4d1e-4728-8465-d42ada33fa5c | Dalvance 500 MG Injection | PSN | 29 | These highlights do not include all the information needed to use DALVANCE ® safely and effectively. See full prescribing information for DALVANCE . DALVANCE ( dalbavancin ) for injection , for intravenous use Initial U.S. Approval: 2014 | 20250113 |
| 4b4674d8-4d1e-4728-8465-d42ada33fa5c | Dalvance 500 MG Injection | SY | 29 | These highlights do not include all the information needed to use DALVANCE ® safely and effectively. See full prescribing information for DALVANCE . DALVANCE ( dalbavancin ) for injection , for intravenous use Initial U.S. Approval: 2014 | 20250113 |